Sherlock Biosciences
Carrie Eglinton Manner currently serves as a Member of the Board of Directors at Team Pennsylvania and Sapphiros, while holding the position of President & CEO at OraSure Technologies since June 2022. Manner has an extensive background in the healthcare industry, demonstrated through prior roles such as Senior Vice President of Advanced Diagnostics at Quest Diagnostics and various leadership positions at GE Healthcare, culminating in the role of President & CEO for multiple divisions. Manner's academic credentials include a Bachelor of Science Degree in Mechanical Engineering from the University of Notre Dame, earned between 1992 and 1996.
This person is not in any teams
This person is not in any offices
Sherlock Biosciences
2 followers
Sherlock Biosciences aims to disrupt molecular diagnostics with better, faster, affordable tests. With their unique Engineering Biology platforms, they are on the cusp of solving challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. They envision a world where their products will enable users to make more effective decisions in any environment, whether in hospitals, industrial settings, the developing world, or at home.